TWO PART SEMINAR SERIES ON CROSS CULTURAL COMMUNICATION
Oct. 12 & Nov. 9 @ 12:00 pm – 1:30 pm
UW Medicine South Lake Union
850 Republican Street
Humans communicate on many levels. We have cultural identities and experiences which increase the probability of miscommunications. This two-part series will include presentations on theory and models, interactive and reflective activities, and take-away tools for professional and personal life. You’ll also enjoy a light lunch with fellow attendees.
We strongly encourage participants to sign up for both sessions described below.
Cross Cultural Communication
WHAT I SAID AND WHAT I MEANT: CROSS CULTURAL COMMUNICATION
October 12, 2017
For this event, we will examine cross-cultural communication theories. This session will explore the ways that cultural values, power, and privilege affect the way we communicate. We’ll put to use tools for questioning assumptions and discuss ways to improve cross-cultural communication skills.
NAVIGATING OUCH MOMENTS: DIALOGUE & LISTENING TOOLS FOR MICROAGGRESSIONS
November 9, 2017
For this event, we’ll examine how to navigate those “ouch” moments that offend or hurt, even though they may be unintended. We’ll review the obstacles that inhibit authentic conversations, as well as practical strategies for what to do or say when you are the target of “ouch” moments, witness to “ouch” moments, and agents of “ouch” moments.
The Institute is supported by grants UL1 TR002319, KL2 TR002317, and TL1 TR002318 from the NIH National Center for Advancing Translational Sciences through the Clinical and Translational Science Awards Program (CTSA). Please help us continue to support your research by citing our grant number(s) in publications we supported.
INBRE pilot grant program for projects that utilize mass spectrometry-based metabolomics.
Montana INBRE is excited to announce a pilot grant program for projects that utilize mass spectrometry-based metabolomics.
Montana INBRE is making available a total of $10,000 to facilitate data generation to establish feasibility, support research projects, and generate data for publications. Projects may focus on targeted or untargeted metabolomics.
- This program is open to current INBRE investigators within the three inaugural RAIN states – Idaho, New Mexico, and Montana.
- Please provide the names and institutional affiliations of project lead and co-leads, as well as the proposed work’s relation to a current, future, or past INBRE project, if any
- Please provide a one-page description of the project that includes a title, summary, hypothesis to be tested, sample types to be analyzed, projected number of samples, and description of the information that would constitute a successful experiment. If you are modeling your study after a publication, please include references
- Please email complete proposal as single .PDF document to: email@example.com
Notes and Deadlines:
- The MSU Proteomics, Metabolomics, and Mass Spectrometry Facility is willing to work with researchers on experimental design and methods for analysis
- Priority will be given to projects that come from investigators in more than one of the Regional Alliance of INBRE Network (RAIN) states, which includes Idaho, Montana, and New Mexico
- Applications will be reviewed on a rolling basis until funds have been exhausted or until Dec 31, 2017.
- Data must be collected before April 30, 2018
Contact and Questions:
- Full details online here >>>
- If you have questions, please contact Montana INBRE Director Brian Bothner firstname.lastname@example.org or MSU Facility Manager Ganesh Balasubramanian: email@example.com
Program Manager / Evaluation Director
Assistant research professor Matthew King and chemistry department chair Owen McDougal contributed to work published in the prestigious journal Nature Communications. The paper “Fortilin binds IRE1α and prevents ER stressfrom signaling apoptotic cell death” describes the role of the protein fortilin in suppressing programmed cell death.
Their work with collaborator Ken Fujise at University of Texas Medical Branch in Galveston, Texas, has led to promising National Institute of Health funding opportunities together with Lisa Warner, a research scientist with the Boise State University Biomolecular Research Center. The current publication serves as a prominent first step in what is likely to be a very fruitful, multi-year, interdisciplinary team project.